Table 1: Patient´s
characteristics (n=259) for all patients in FIGO-stages IA-IIB. The study
included 253 patients after six patients with other histology were, excluded
(clear cell tumors (n = 2), neuroendocrine tumors (n = 2) and spino-celluler
tumors (n = 2)) which, are presented in this table, but not included in in this
work.
|
Patient´s
characteristics (n=259) |
n |
% |
|
Age
(median) |
45.9
years (range 22-83 years) |
|
|
FIGO-stage |
259 |
|
|
IA |
45 |
(17.4) |
|
IB |
162 |
(62.5) |
|
IIA |
14 |
(5.4) |
|
IIB |
38 |
(14.7) |
|
Histopathology |
|
|
|
Squamous
cell carcinoma |
150 |
(57.9) |
|
Adenocarcinoma |
74 |
(28.6) |
|
Adeno-squamous |
29 |
(11.2) |
|
Other* |
6 |
(4.6) |
|
Tumor
grade |
|
|
|
G1 |
58 |
(21.4) |
|
G2 |
77 |
(28.4) |
|
G3 |
89 |
(32.8) |
|
Ungraded |
35 |
(12.9) |
|
Type
of Operative treatment |
210 |
|
|
Trachelectomy |
27 |
(13.1) |
|
Total
hysterectomy |
30 |
(14.3) |
|
Radical
hysterectomy |
153 |
(72.6) |
|
Primary
oncological treatment |
49 |
|
|
Radio-chemotherapy |
40 |
(81.6) |
|
Primary
radiotherapy |
9 |
(18.4) |
|
Postoperative
oncological treatment |
29 |
|
|
Radio-chemotherapy |
27 |
(93.1) |
|
Radiotherapy |
2 |
(6.9) |
Other*
tumors of other histology (clear cell tumors (n = 2), neuroendocrine tumors (n
= 2) and spino-cellular tumors (n = 2) are presented in this table, but not
included in this work.